US Patent No: 6,759,520

Number of patents in Portfolio can not be more than 2000

Chimeric analgesic peptides

Stats

ATTORNEY / AGENT: (SPONSORED)
 

Importance

Loading Importance Indicators... loading....

Abstract

The present invention provides a novel chimeric peptide containing an opioid peptide moiety and a nociceptive peptide moiety for producing analgesia.

Loading the Abstract Image... loading....

First Claim

Related Publications

Loading Related Publications... loading....

Patent Owner(s)

Patent OwnerAddressTotal Patents
NEW ENGLAND MEDICAL CENTER HOSPITALS, INC.BOSTON, MA104
MIDICAL RESEARCH CENTER OF THE POLISH ACADEMY OF SCIENCESBOSTON, MA, PL1

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Carr, Daniel B Chestnut Hill, MA 10 21
Kream, Richard Roslindale, MA 3 18
Lipkowski, Andrzej W Warsaw, PL 10 36
Misicka-Kesik, Aleksandra Piastow, PL 4 18

Cited Art

Patent Info (Count) # Cites Year
 
ADVANCED TARGETING SYSTEMS, INC. (1)
6,063,758 Substance P-Saporin (SP-SAP) conjugates and methods of use thereof 12 1997
 
THE LYNX PROJECT LIMITED (1)
6,310,072 Production of analgesic synergy by co-administration of sub-analgesic doses of a MU opioid agonist and a kappa-2 opioid agonist 23 1997
 
TRUSTEES OF TUFTS COLLEGE (1)
5,891,842 Methodology for eliciting an analgesic response in a living subject 25 1996

Patent Citation Ranking

Forward Cites

Patent Info (Count) # Cites Year
 
CORNELL RESEARCH FOUNDATION, INC. (7)
7,704,954 Method and carrier complexes for delivering molecules to cells 0 2004
7,550,439 Methods for reducing oxidative damage 1 2005
7,781,405 Methods for reducing oxidative damage 2 2006
7,541,340 Methods for reducing CD36 expression 0 2006
8,143,219 Methods for prevention and treatment of acute renal injury 0 2009
7,811,987 Methods for reducing CD36 expression 1 2009
8,148,322 Method and carrier complexes for delivering molecules to cells 0 2009
 
INSTITUT DE RECHERCHES CLINIQUES DE MONTREAL (2)
7,576,061 Methods for preventing mitochondrial permeability transition 1 2004
7,718,620 Methods for preventing or treating ischemia-reperfusion injury of the kidney 2 2006
 
CHIMERACOM, LLC (1)
7,214,657 Method of transporting a chimeric hybrid molecule across the blood brain barrier 0 2003
 
EAST CAROLINA UNIVERSITY (1)
8,088,727 Method for reducing the risk, lessening the symptom, or delaying the onset of insulin resistance by administering SS-31 0 2009
 
LUMENIR, INC. (1)
8,404,646 Methods for preventing or treating mitochondrial permeability transition 0 2011
 
THE REGENTS OF THE UNIVERSITY OF MICHIGAN (1)
7,825,231 Method of amidated peptide biosynthesis and delivery in vivo: endomorphin-2 for pain therapy 1 2006
 
UNIVERSITY OF ARIZONA (1)
8,026,218 Bifunctional analgesic compounds for opioid receptor agonists and neurokinin-1 receptor antagonists 0 2007
 
WOLFE, DARREN (1)
8,003,622 Peptide biosynthesis and pain therapy 0 2010

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 6, 2016
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00